List of insiders holdings for enGene Holdings Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| Forbion Growth Sponsor FEAC I B.V. Forbion Growth Opportunities Fund I Cooperatief U.A. Forbion Growth Management B.V. 10% Owner | 2024-11-01 16:04:56 | 9,201,434 0 | 9,201,434 | Form 13D |
| Forbion Growth Opportunities Fund I Cooperatief U.A. Forbion Growth Management B.V. 10% Owner | 2024-11-01 16:15:08 | 3,032,430 3,765,932 | 6,798,362 | Form 4 |
| Forbion Capital Fund III Cooperatief U.A. Forbion III Management B.V. 10% Owner | 2024-02-14 07:21:55 | 3,369,275 0 | 3,369,275 | Form 13G |
| BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N 10% Owner | 2024-02-22 16:45:13 | 3,196,439 0 | 3,196,439 | Form 13G |
| FONDS DE SOLIDARITE DES TRAVAILLEURS DU QUEBEC 10% Owner | 2024-04-22 17:22:10 | 3,036,153 0 | 3,036,153 | Form 4 |
| Lumira Capital Investment Management Inc. 10% Owner | 2024-02-21 16:20:10 | 0 2,855,648 | 2,855,648 | Form 4 |
| Hanson Jason David Chief Executive Officer | 2023-11-02 16:09:58 | 1,216,266 0 | 1,216,266 | Form 4 |
| Nichols Alexander Julian Pres. & Chief Operating Ofc. | 2023-11-02 16:10:59 | 279,859 0 | 279,859 | Form 4 |
| Daws D. Ryan Chief Financial Officer | 2023-12-04 17:52:42 | 232,000 0 | 232,000 | Form 4 |
| Giguere Lee Chief Legal Ofc. and Corp Secy | 2024-03-19 16:05:31 | 225,000 0 | 225,000 | Form 4 |
| Connolly Joan Chief Technology Officer | 2024-10-22 16:07:13 | 210,000 0 | 210,000 | Form 4 |
| Sullivan James Crowley Chief Scientific Officer | 2023-11-02 16:09:31 | 207,410 0 | 207,410 | Form 4 |
| BRYCE RICHARD PAUL Chief Medical Officer | 2023-12-04 17:55:37 | 153,000 0 | 153,000 | Form 4 |
| Pruthi Raj Som Chief Medical Officer | 2024-07-25 20:32:45 | 110,000 0 | 110,000 | Form 4 |
| CHEUNG ANTHONY TZEYEW Chief Scientific Officer | 2024-10-22 16:08:23 | 100,000 0 | 100,000 | Form 4 |
| Joustra Wouter Director | 2024-06-18 16:08:01 | 40,000 0 | 40,000 | Form 4 |
| HASTINGS PAUL J Director | 2024-06-18 16:08:51 | 40,000 0 | 40,000 | Form 4 |
| BRUNK GERALD A Director | 2024-06-18 16:04:17 | 20,000 0 | 20,000 | Form 4 |
| Bos Jasper Director | 2024-06-18 16:05:02 | 20,000 0 | 20,000 | Form 4 |
| Glickman Richard M Director | 2024-06-18 16:06:48 | 20,000 0 | 20,000 | Form 4 |
| Zoth Lota S. Director | 2024-06-18 16:09:40 | 20,000 0 | 20,000 | Form 4 |
| Cooper Ronald Harold Wilfred Chief Executive Officer | 2024-10-01 08:02:44 | 10,000 0 | 10,000 | Form 4 |
| Grassin Alexandre Jean-Rene Erwan Int. Chief Financial Officer | 2023-10-31 18:02:41 | 0 0 | 0 | Form 3 |